THERESE LUCIETTO-SIERADZKI: Open Payments
NPI 1699708636 · BELVIDERE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 92 payments from 22 companies in 2025. Trend: 2023 $1,324 · 2024 $1,805 · 2025 $1,766
Food & beverage: $1,766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $338 |
| AstraZeneca Pharmaceuticals LP | 3 | $307 |
| GENZYME CORPORATION | 3 | $149 |
| Kowa Pharmaceuticals America, Inc. | 17 | $140 |
| Lilly USA, LLC | 12 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Esperion Therapeutics, Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $72 |
| Viatris Specialty LLC | 4 | $72 |
| Orexo US, Inc. | 2 | $54 |
Products named: VRAYLAR, DUPIXENT, ZORYVE, MOUNJARO, AIRSUPRA, TEZSPIRE, BREZTRI, LINZESS.
Industry payments across IL — which companies pay providers there.
